Neurophysiological Attention Test (NAT) for Objective Assessment of Adult ADHD

ClinicalTrials.gov ID: NCT02756286

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT02756286. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Nov 14, 2026, 10:28 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to refine a new assessment tool for Attention Deficit/Hyperactivity Disorder (ADHD) and then to test its validity (i.e. ability to discriminate between individuals with ADHD and healthy controls.

Study identification

NCT ID: NCT02756286
Recruitment status: Completed
Study type: Observational
Phase: Not listed
Lead sponsor: Think Now Incorporated; Industry
Enrollment: 258 participants

Conditions and interventions

Conditions

Attention Deficit Hyperactivity Disorder

Interventions

NAT electroencephalography (EEG) test Other

Other

Eligibility (public fields only)

Age range: 18 Years to 40 Years
Sex: All
Healthy volunteers: Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Jan 1, 2017 (Actual)
Primary completion: Jun 1, 2018 (Actual)
Completion: Jul 5, 2018 (Actual)
Last update posted: Sep 19, 2018

2017 – 2018

United States locations

U.S. sites: 3
U.S. states: 2
U.S. cities: 3

Facility	City	State	ZIP	Site status
University of California Berkeley	Berkeley	California	94720	—
UCLA Semel Institute	Los Angeles	California	90095	—
Oregon Health & Science University	Portland	Oregon	97239	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT02756286, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Sep 19, 2018 · Synced Nov 14, 2026